675. Deputy Colm Burke asked the Minister for Health whether she will request or support a Health Technology Assessment by HIQA examining the extension of continuous glucose monitoring access to people with other forms of diabetes, including Type 2 diabetes, cystic-fibrosis-related diabetes and Type 3c diabetes, with eligibility based on clinical need. [67241/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Colm Burke under the heading Healthcare Policy.
38 questions match, newest first.
1859. Deputy Colm Burke asked the Minister for Health whether she intends to use Ireland’s Presidency of the Council of the EU in 2026 to advance a renewed EU-level political commitment on HIV prevention, building on the legacy of the Dublin Declaration of 2004; and if she will make a statement on the matter. [41766/26]
1860. Deputy Colm Burke asked the Minister for Health whether HIV prevention will be considered as part of Ireland’s health priorities during its Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration, particularly in the context of the EU-wide goal of ending HIV as a public health threat by 2030; and if she will make a statement on the matter. [41767/26]
1861. Deputy Colm Burke asked the Minister for Health whether Ireland will support the development of a renewed EU HIV/AIDS Action Plan, given that the previous EU action plan lapsed in 2016; and whether this issue will be raised during Ireland’s Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration. [41768/26]
1862. Deputy Colm Burke asked the Minister for Health the steps Ireland will take during its Presidency of the Council of the EU to support improved access across Europe to HIV prevention tools, including testing, PrEP, community-led services and stigma-free care; and if she will make a statement on the matter. [41769/26]
2252. Deputy Colm Burke asked the Minister for Health the up-to-date position in respect of the application for pricing and reimbursement of skyclarys (omaveloxolone) for the treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older; and if she will make a statement on the matter. [43399/26]
233. Deputy Colm Burke asked the Minister for Health if she is aware of concerns regarding the impact of the discontinuation of the Peer Payment Register in 2019 on the involvement of service users and family facilitators in recovery-focused programmes such as EOLAS; when her Department's review of alternative models to remunerate sessional peer facilitators will be published; and if she will make a statement on the …
963. Deputy Colm Burke asked the Minister for Health the action her Department is taking in view of the barriers currently faced by patients in Ireland living with lipoedema (details supplied); and if she will make a statement on the matter. [22057/26]
964. Deputy Colm Burke asked the Minister for Health if the HSE working group established in 2023 to develop a national care pathway for lipoedema has completed its work; when the pathway is expected to be published; whether patient advocacy organisations (details supplied) will be included in the development and implementation of this pathway; and if she will make a statement on the matter. [22058/26]
965. Deputy Colm Burke asked the Minister for Health if her Department has engaged with private health insurers to review the operation of the coverage for medically indicated liposuction procedures for lipoedema patients (details supplied); and if she will make a statement on the matter. [22059/26]
974. Deputy Colm Burke asked the Minister for Health the details of her Departments plans to implement the EU initiative of “Safe Hearts” to shape cardiovascular policy in Ireland in 2026; and if she will make a statement on the matter. [17235/26]
977. Deputy Colm Burke asked the Minister for Health the way in which Ireland can lead European Union conversation on cardiovascular health during the upcoming Presidency of the Council of the European Union; and if she will make a statement on the matter. [17238/26]
661. Deputy Colm Burke asked the Minister for Health the steps that have been taken to progress the lymphoedema and lipoedema model of care further to successful outcomes from Proof-of-Concept services; and if she will make a statement on the matter. [13894/26]
2451. Deputy Colm Burke asked the Minister for Health if funding for the lymphoedema and lipoedema model was provided for in Budget 2026; if not, whether consideration would be given to providing funding for same, considering that international studies show that the cost to treat patients could be reduced by 87%, if comprehensive lymphedema services were introduced; and if she will make a statement on the matter. [16…
505. Deputy Colm Burke asked the Minister for Health if Ireland's new cardiovascular plan aims to tackle the high levels of atherosclerotic cardiovascular disease (ASCVD) in Ireland by focusing on early detection and effective management of risk factors for ASCVD, such as cholesterol, blood pressure, diabetes, obesity, and smoking; and if she will make a statement on the matter. [66870/25]
506. Deputy Colm Burke asked the Minister for Health if Ireland's new cardiovascular plan aims to focus on the specific role which cholesterol plays in atherosclerotic cardiovascular disease (ASCVD); and if she will make a statement on the matter. [66871/25]
1630. Deputy Colm Burke asked the Minister for Health the steps her Department has taken following the final report on the inclusion health framework (details supplied) which was submitted earlier in spring 2025; the further actions she and her Department plan to take on this report; and if she will make a statement on the matter. [57774/25]
302. Deputy Colm Burke asked the Minister for Health the extent to which Ireland contributes to European commission expert groups covering the healthcare sector; the identities of Irish representatives to these groups; the value these groups provide when it comes to policy making; and if she will make a statement on the matter. [54209/25]
2187. Deputy Colm Burke asked the Minister for Health the discussions that have taken place regarding the continuing future use of Crumlin Children's Hospital and Temple Street Children's Hospital after the opening of the National Children's Hospital in 2026; and if she will make a statement on the matter. [45014/25]
2188. Deputy Colm Burke asked the Minister for Health whether consideration has been given to using Crumlin Children's Hospital as an elective surgery hospital for Dublin after the opening of the National Children’s Hospital in 2026; and if she will make a statement on the matter. [45015/25]
2189. Deputy Colm Burke asked the Minister for Health whether consideration has been given to using Temple St Children's Hospital as a step down facility following the opening of the National Children’s Hospital in 2026; and if she will make a statement on the matter. [45016/25]
2193. Deputy Colm Burke asked the Minister for Health the measures her Department plans to implement to ensure that each severe asthma clinic has a qualified advanced nurse practitioner; and if she will make a statement on the matter. [45033/25]
2194. Deputy Colm Burke asked the Minister for Health if her Department will commit to allocating funding to universally subsidise inhaled asthma medications on a phased basis; and if she will make a statement on the matter. [45034/25]
2195. Deputy Colm Burke asked the Minister for Health if consideration will be given to reimbursing the financial cost of tezepelumab for asthma patients; and if she will make a statement on the matter. [45035/25]
2196. Deputy Colm Burke asked the Minister for Health if consideration will be given to launching a public campaign to disincentivize smoking and e-cigarette use; and if she will make a statement on the matter. [45037/25]